AI Accelerates Breakthroughs Across Life Sciences and Healthcare

Key Intelligence

• ■New AI models like "Evo 2" are advancing genetic engineering by enabling the modeling and design of genetic code across all life domains.
• ■Strategic partnerships, such as Insilico Medicine and Liquid AI, are launching lightweight AI foundation models specifically for drug discovery, including on-premise solutions.
• ■AI is increasingly applied in medical diagnostics and patient care, with models for cervical spondylosis diagnosis, oncology data analysis, and a post-surgical platform receiving FDA Breakthrough Designation.
• ■Industry leaders, including Temasek's CEO, anticipate AI will have a profound and transformative impact on the pharmaceutical and biotechnology sectors.
• ■Ongoing research also highlights challenges, such as the potential for AI pathology models to take unreliable shortcuts when identifying cancer biomarkers, necessitating careful validation.